Zobrazeno 1 - 10
of 49
pro vyhledávání: '"Kaushal Desai"'
Autor:
Javier J. Barranco-Trabi, MD, Kaushal Desai, MD, Daniel Chen, MD, Dwight Kellicut, MD, Wiberg Brandon, DO, Sharon Chi, DO, Nathanial K. Copeland, MD, Edwin Kamau, PhD, Viseth Ngauy, MD
Publikováno v:
Journal of Vascular Surgery Cases and Innovative Techniques, Vol 10, Iss 6, Pp 101454- (2024)
Chronic venous disease is a common condition causing pain, discomfort, and skin changes that effect quality of life and productivity. Various treatment modalities have been developed to manage retrograde venous blood flow and its associated complicat
Externí odkaz:
https://doaj.org/article/24a90a1685a44a0fb4a5e7000ffece5f
Publikováno v:
JMIR Medical Informatics, Vol 12, p e47744 (2024)
BackgroundThe importance of real-world evidence is widely recognized in observational oncology studies. However, the lack of interoperable data quality standards in the fragmented health information technology landscape represents an important challe
Externí odkaz:
https://doaj.org/article/e9d2a36ab9914a0696ebbfa02a4fecb6
Autor:
Alnecia R Nisbett, Xiaoqin Yang, Patrick Squires, Santosh Gautam, Kaushal Desai, Monika Raut, Akash Nahar
Publikováno v:
Future oncology (London, England).
Aim: Limited real-world data exist on treatment patterns and clinical outcomes for patients with relapsed/refractory (R/R) classical Hodgkin's lymphoma (cHL). Methods: This study used the ConcertAI Oncology Dataset to assess treatment patterns, real-
Autor:
Erik R Dubberke, Justin T Puckett, Engels N Obi, Sachin Kamal-Bahl, Kaushal Desai, Bruce Stuart, Jalpa A Doshi
Publikováno v:
Open Forum Infectious Diseases. 9
Background The 2017 Infectious Diseases Society of America/Society for Healthcare Epidemiology of America (IDSA/SHEA) Clostridium (Clostridioides) difficile infection (CDI) guideline update recommended treatment with fidaxomicin or vancomycin for CDI
Autor:
Shuvayu S Sen, Monika Raut, Dominique Lejeune, Guillaume Germain, François Laliberté, Philippe Armand, Xiaoqin Yang, Mei Sheng Duh, Kaushal Desai
Publikováno v:
The Oncologist
Background Diffuse large B‐cell lymphoma (DLBCL) represents the most common subtype of non‐Hodgkin lymphoma in the U.S., but current real‐world data are limited. This study was conducted to describe real‐world characteristics, treatment patte
Autor:
Shuvayu S Sen, Monika Raut, Sean D. MacKnight, Mei Sheng Duh, Kaushal Desai, Xiaoqin Yang, Guillaume Germain, François Laliberté, Akash Nahar
Publikováno v:
Targeted Oncology
Background Patients with classical Hodgkin lymphoma (cHL) relapsed or refractory (R/R) disease who relapse after or are ineligible for autologous stem cell transplantation have a poor prognosis. Recently, the anti-PD1 monoclonal antibodies nivolumab
Autor:
Neha Agrawal, Xiaoqin Yang, Sagnik Chatterjee, Kaushal Desai, Kirti Mirchandani, Shuvayu S Sen, Eric M. Sarpong
Publikováno v:
Pediatric Health, Medicine and Therapeutics. 11:421-428
Background Neurofibromatosis type 1 (NF1) is an autosomal dominant genetic condition which predisposes individuals to tumors of the nervous system, skin, bones, and eyes. Plexiform neurofibromas (PNs) occur in 20-50% of NF1 cases, causing multiple mo
Publikováno v:
Journal of the National Comprehensive Cancer Network. 18:HSR20-089
Autor:
Kirti Mirchandani, Sagnik Chatterjee, Neha Agrawal, Eric M. Sarpong, Kaushal Desai, Xiaoqin Yang, Shuvayu S Sen
Publikováno v:
Journal of the National Comprehensive Cancer Network. 18:HSR20-111
Autor:
Erik R. Dubberke, Justin T. Puckett, Engels N. Obi, Sachin Kamal-Bahl, Kaushal Desai, Bruce Stuart, Jalpa A. Doshi
Publikováno v:
Gastroenterology. 162:S-157